Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 375 of 1467 entries
View as:

An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem Cells

Phase: N/A Priority: Normal
NCT ID: NCT01753453 Org: User:
Start: 06/30/13 End: 09/30/16 Due: 09/30/17

A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM)

Phase: N/A Priority: Normal
NCT ID: NCT02803918 Org: User:
Start: 05/17/17 End: 01/27/20 Due: 01/27/21

Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2)

Phase: N/A Priority: Normal
NCT ID: NCT04202679 Org: User:
Start: 01/16/20 End: 11/22/21 Due: 11/22/22

Euglycemic Clamp Study Comparing Two New Insulin Glargine Formulations in Subjects With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01838083 Org: User:
Start: 04/30/13 End: 08/31/13 Due: 08/31/14

Evaluation of Efficacy and Safety of AVE5530 in Patients With Primary Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT00718965 Org: User:
Start: 07/31/08 End: 06/30/09 Due: 06/30/10

Repeated Dose Study With a New Insulin Glargine Formulation and Lantus® on 24-hour Glucose Profile in Japanese Patients With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01676233 Org: User:
Start: 09/30/12 End: 08/31/13 Due: 08/31/14

Interaction Study to Evaluate the Effects of Mefenamic Acid on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin in Healthy Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03070678 Org: User:
Start: 03/14/17 End: 04/18/17 Due: 04/18/18

A Study in Male and Female Adult Patients With Atopic Dermatitis Treated With Dupilumab in Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT05442645 Org: User:
Start: 07/20/22 End: 06/18/24 Due: 06/18/25

A Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney Transplant

Phase: N/A Priority: Normal
NCT ID: NCT03099122 Org: User:
Start: 08/16/17 End: 11/12/19 Due: 11/12/20

AVE7688 in Patients With Mild to Moderate Blood Pressure

Phase: N/A Priority: Normal
NCT ID: NCT00284128 Org: User:
Start: 12/31/05 End: 03/31/08 Due: 03/31/09

GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00707031 Org: User:
Start: 06/30/08 End: 11/30/10 Due: 11/30/11

Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00361738 Org: User:
Start: 07/31/06 End: 01/31/08 Due: 01/31/09

Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

Phase: N/A Priority: Normal
NCT ID: NCT05263206 Org: User:
Start: 02/15/22 End: 08/25/27 Due: 08/25/28

Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01515748 Org: User:
Start: 12/30/11 End: 12/13/21 Due: 12/13/22

Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials

Phase: N/A Priority: Normal
NCT ID: NCT05492578 Org: User:
Start: 08/22/22 End: 12/29/28 Due: 12/29/29

FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)

Phase: N/A Priority: Normal
NCT ID: NCT06111586 Org: User:
Start: 12/11/23 End: 10/27/28 Due: 10/27/29

Dermatological Evaluation of Topic Compatibility-Dermacyd Tina Gel Sweet Flower

Phase: N/A Priority: Normal
NCT ID: NCT00668668 Org: User:
Start: 12/31/07 End: - Due: -

Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT02274740 Org: User:
Start: 04/30/15 End: 08/31/15 Due: 08/31/16

Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild and Moderate Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01126086 Org: User:
Start: 05/31/10 End: 04/30/11 Due: 04/30/12

Study of AVE1642 (IGF-1R/CD221) in Combination With Fulvestrant (Faslodex®) in Postmenopausal Patients With Advanced Hormono-dependent Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00774878 Org: User:
Start: 10/31/08 End: 11/30/10 Due: 11/30/11

Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α Blockers

Phase: N/A Priority: Normal
NCT ID: NCT01217814 Org: User:
Start: 11/30/10 End: 09/30/11 Due: 09/30/12

Scintigraphy Study to Compare the Antireflux Activity of the Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03065816 Org: User:
Start: 02/09/17 End: 05/02/17 Due: 05/02/18

Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT01001221 Org: User:
Start: 11/30/09 End: 10/31/11 Due: 10/31/12

Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent

Phase: N/A Priority: Normal
NCT ID: NCT02485691 Org: User:
Start: 11/09/15 End: 03/15/21 Due: 03/15/22

Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00751114 Org: User:
Start: 11/30/08 End: 07/31/11 Due: 07/31/12